BioSpace News Archive

Press Releases

BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

October 29, 2024
·
4 min read
Press Releases

SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years

October 29, 2024
·
5 min read
Press Releases

Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months

October 29, 2024
·
5 min read
Press Releases

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

October 29, 2024
·
4 min read
Press Releases

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 28, 2024

October 29, 2024
·
1 min read
Press Releases

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

October 29, 2024
·
4 min read
Press Releases

Cardiawave Announces Positive Six-Month Data from Valvosoft Pivotal Study at Transcatheter Cardiovascular Therapeutics (TCT) Conference

October 29, 2024
·
4 min read
Press Releases

NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November 2024

October 29, 2024
·
3 min read
Press Releases

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

October 29, 2024
·
7 min read
Press Releases

New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information

October 29, 2024
·
3 min read